AVITA Medical, Inc. (AVH.AX)
| Previous close | 3.0000 |
| Open | 3.0800 |
| Bid | 3.1100 x 0 |
| Ask | 3.1700 x 0 |
| Day's range | 3.0800 - 3.1700 |
| 52-week range | 2.3400 - 6.2700 |
| Volume | |
| Avg. volume | 360,399 |
| Market cap | 405.057M |
| Beta (5Y monthly) | 1.53 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.5400 |
| Earnings date | 08 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 4.52 |
GlobeNewswireAVITA Medical to Announce Second Quarter 2024 Financial Results
VALENCIA, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that it will report its second quarter 2024 financial results after the close of the U.S. financial markets on Thursday, August 8, 2024. AVITA Medical will host a conference call and webcast that day at 1:30 p.m. Pacific Time (Friday, August 9, 2024, at 6
- GlobeNewswire
AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary
Donna Shiroma retires after distinguished service as General CounselVALENCIA, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced the appointment of Nicole Linda Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary, effective July 1, 2024. Ms. Kelsey has more than two decades of executive legal expe
Simply Wall St.Institutions own 46% of AVITA Medical, Inc. (NASDAQ:RCEL) shares but retail investors control 50% of the company
Key Insights The considerable ownership by retail investors in AVITA Medical indicates that they collectively have a...
